A study protocol for a randomised open-label clinical trial of artesunate-mefloquine versus chloroquine in patients with non-severe Plasmodium knowlesi malaria in Sabah, Malaysia (ACT KNOW trial)

INTRODUCTION: Malaria due to Plasmodium knowlesi is reported throughout South-East Asia, and is the commonest cause of it in Malaysia. P. knowlesi replicates every 24 h and can cause severe disease and death. Current 2010 WHO Malaria Treatment Guidelines have no recommendations for the optimal treat...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Grigg, M J, William, T, Dhanaraj, P, Menon, J, Barber, B E, von Seidlein, L, Rajahram, G, Price, R N, Anstey, N M, Yeo, T W
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMJ Publishing Group 2014
Pynciau:
Infectious Diseases
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4139630/
https://ncbi.nlm.nih.gov/pubmed/25138814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2014-006005
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg